Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,769 | -- | 123,364 | |
| Aug 17, 2021 | SVP/GM, Vascular Access | Form 4 | Other acquisition or disposition | 8,777 | -- | 8,777 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,777 | -- | 8,777 | |
| Jul 20, 2022 | SVP International | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,803 | -- | 8,803 | |
| Mar 14, 2006 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,828 | $4.35 | 432,142 | |
| Mar 14, 2006 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,828 | -- | 17,308 | |
| Aug 03, 2011 | EVP - CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,000 | -- | 37,977 | |
| Sep 04, 2009 | Vice-President - Research | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,000 | -- | 9,000 | |
| Mar 14, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 9,000 | $4.35 | 51,889 | |
| Mar 14, 2006 | Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 9,000 | $25.02 | 42,889 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.